Question 1

What is LOPJLB’s current signal on MREO?

Accepted Answer

LOPJLB’s latest quantitative signal on Mereo BioPharma Group plc (MREO) is BUY in a RECOVERY regime. Signals are updated daily.

Question 2

What market regime is MREO in?

Accepted Answer

Mereo BioPharma Group plc (MREO) is currently classified in the RECOVERY HMM market regime on LOPJLB.

Question 3

What does Mereo BioPharma Group plc (MREO) do?

Accepted Answer

Mereo BioPharma Group plc, a London-based biopharmaceutical firm established in 2015, specializes in developing and commercializing innovative therapies for oncology and rare conditions. Operating both in the United Kingdom and internationally, the company boasts a diverse product pipeline. Its primary oncology asset, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor, is presently unde…

Question 4

Where is Mereo BioPharma Group plc based / listed?

Accepted Answer

Mereo BioPharma Group plc is based in GB, listed on NASDAQ.

Mereo BioPharma Group plc (MREO)

Key stats

Industry peers

Prediction markets

Company news